Effect of naloxone on plasma insulin, insulin-like growth factor I, and its binding protein 1 in patients with polycystic ovarian disease**Supported by grants from the Academy of Finland, Helsinki, Finland; the Sigrid Jusélius Foundation, Helsinki, Finland; and the Finnish Social Insurance Institution, Helsinki, Finland.
1990 ◽
Vol 54
(3)
◽
pp. 434-437
◽
1991 ◽
Vol 55
(5)
◽
pp. 895-899
◽
1990 ◽
Vol 163
(6)
◽
pp. 1992-1997
◽